nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP1A2—Carmustine—malignant glioma	0.257	0.57	CbGbCtD
Aprepitant—CYP3A4—Temozolomide—malignant glioma	0.194	0.43	CbGbCtD
Aprepitant—Wound dehiscence—Carmustine—malignant glioma	0.0228	0.0799	CcSEcCtD
Aprepitant—TACR3—brainstem—malignant glioma	0.00999	0.215	CbGeAlD
Aprepitant—TACR3—telencephalon—malignant glioma	0.00886	0.191	CbGeAlD
Aprepitant—Sensory disturbance—Temozolomide—malignant glioma	0.00818	0.0287	CcSEcCtD
Aprepitant—Altered state of consciousness—Temozolomide—malignant glioma	0.00549	0.0193	CcSEcCtD
Aprepitant—TACR3—central nervous system—malignant glioma	0.00504	0.108	CbGeAlD
Aprepitant—TACR3—cerebellum—malignant glioma	0.00492	0.106	CbGeAlD
Aprepitant—Febrile neutropenia—Carmustine—malignant glioma	0.00436	0.0153	CcSEcCtD
Aprepitant—Visual acuity reduced—Temozolomide—malignant glioma	0.00426	0.015	CcSEcCtD
Aprepitant—Febrile neutropenia—Temozolomide—malignant glioma	0.00421	0.0148	CcSEcCtD
Aprepitant—Deep vein thrombosis—Temozolomide—malignant glioma	0.00417	0.0146	CcSEcCtD
Aprepitant—Oral candidiasis—Carmustine—malignant glioma	0.00413	0.0145	CcSEcCtD
Aprepitant—TACR3—brain—malignant glioma	0.004	0.0861	CbGeAlD
Aprepitant—Oral candidiasis—Temozolomide—malignant glioma	0.00399	0.014	CcSEcCtD
Aprepitant—Embolism—Temozolomide—malignant glioma	0.00395	0.0139	CcSEcCtD
Aprepitant—Cyst—Carmustine—malignant glioma	0.00392	0.0138	CcSEcCtD
Aprepitant—TACR1—brainstem—malignant glioma	0.00387	0.0832	CbGeAlD
Aprepitant—TACR1—telencephalon—malignant glioma	0.00343	0.0739	CbGeAlD
Aprepitant—Rigors—Temozolomide—malignant glioma	0.00311	0.0109	CcSEcCtD
Aprepitant—Herpes simplex—Temozolomide—malignant glioma	0.00275	0.00966	CcSEcCtD
Aprepitant—Gait disturbance—Carmustine—malignant glioma	0.00269	0.00944	CcSEcCtD
Aprepitant—Pulmonary embolism—Carmustine—malignant glioma	0.00262	0.00921	CcSEcCtD
Aprepitant—Gait disturbance—Temozolomide—malignant glioma	0.0026	0.00912	CcSEcCtD
Aprepitant—Respiratory failure—Temozolomide—malignant glioma	0.00258	0.00906	CcSEcCtD
Aprepitant—Musculoskeletal pain—Temozolomide—malignant glioma	0.00257	0.00901	CcSEcCtD
Aprepitant—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00254	0.0089	CcSEcCtD
Aprepitant—Pulmonary embolism—Temozolomide—malignant glioma	0.00254	0.0089	CcSEcCtD
Aprepitant—Depressed level of consciousness—Carmustine—malignant glioma	0.00253	0.00889	CcSEcCtD
Aprepitant—Candida infection—Carmustine—malignant glioma	0.0025	0.00879	CcSEcCtD
Aprepitant—Depressed level of consciousness—Temozolomide—malignant glioma	0.00245	0.00859	CcSEcCtD
Aprepitant—Candida infection—Temozolomide—malignant glioma	0.00242	0.0085	CcSEcCtD
Aprepitant—TACR1—spinal cord—malignant glioma	0.00241	0.0518	CbGeAlD
Aprepitant—Neoplasm—Carmustine—malignant glioma	0.00237	0.00833	CcSEcCtD
Aprepitant—Neoplasm—Temozolomide—malignant glioma	0.00229	0.00805	CcSEcCtD
Aprepitant—Thrombophlebitis—Carmustine—malignant glioma	0.0022	0.00772	CcSEcCtD
Aprepitant—Diabetes mellitus—Carmustine—malignant glioma	0.00219	0.00769	CcSEcCtD
Aprepitant—Thrombophlebitis—Temozolomide—malignant glioma	0.00213	0.00746	CcSEcCtD
Aprepitant—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00212	0.00743	CcSEcCtD
Aprepitant—Hot flush—Temozolomide—malignant glioma	0.00197	0.00691	CcSEcCtD
Aprepitant—TACR1—central nervous system—malignant glioma	0.00195	0.042	CbGeAlD
Aprepitant—Menopausal symptoms—Temozolomide—malignant glioma	0.00195	0.00685	CcSEcCtD
Aprepitant—Thirst—Temozolomide—malignant glioma	0.00193	0.00679	CcSEcCtD
Aprepitant—Hyponatraemia—Carmustine—malignant glioma	0.00191	0.00671	CcSEcCtD
Aprepitant—Hypokalaemia—Carmustine—malignant glioma	0.00173	0.00608	CcSEcCtD
Aprepitant—Dehydration—Temozolomide—malignant glioma	0.00171	0.00601	CcSEcCtD
Aprepitant—Muscular weakness—Carmustine—malignant glioma	0.00168	0.0059	CcSEcCtD
Aprepitant—Hypokalaemia—Temozolomide—malignant glioma	0.00167	0.00588	CcSEcCtD
Aprepitant—Breast disorder—Temozolomide—malignant glioma	0.00166	0.00584	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00166	0.00582	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00166	0.00582	CcSEcCtD
Aprepitant—Dysphagia—Carmustine—malignant glioma	0.00165	0.00578	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00162	0.0057	CcSEcCtD
Aprepitant—Muscular weakness—Temozolomide—malignant glioma	0.00162	0.0057	CcSEcCtD
Aprepitant—Abdominal distension—Temozolomide—malignant glioma	0.0016	0.00562	CcSEcCtD
Aprepitant—Dysphagia—Temozolomide—malignant glioma	0.00159	0.00558	CcSEcCtD
Aprepitant—Sweating increased—Temozolomide—malignant glioma	0.00155	0.00544	CcSEcCtD
Aprepitant—TACR1—brain—malignant glioma	0.00155	0.0333	CbGeAlD
Aprepitant—Neutropenia—Carmustine—malignant glioma	0.00154	0.0054	CcSEcCtD
Aprepitant—Neutropenia—Temozolomide—malignant glioma	0.00149	0.00522	CcSEcCtD
Aprepitant—Dysuria—Temozolomide—malignant glioma	0.00149	0.00522	CcSEcCtD
Aprepitant—Hyperglycaemia—Carmustine—malignant glioma	0.00148	0.00521	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00148	0.00519	CcSEcCtD
Aprepitant—Pneumonia—Carmustine—malignant glioma	0.00148	0.00518	CcSEcCtD
Aprepitant—Pollakiuria—Temozolomide—malignant glioma	0.00147	0.00516	CcSEcCtD
Aprepitant—Photosensitivity reaction—Temozolomide—malignant glioma	0.00145	0.0051	CcSEcCtD
Aprepitant—Weight increased—Temozolomide—malignant glioma	0.00145	0.00508	CcSEcCtD
Aprepitant—Renal failure—Carmustine—malignant glioma	0.00144	0.00506	CcSEcCtD
Aprepitant—Weight decreased—Temozolomide—malignant glioma	0.00144	0.00505	CcSEcCtD
Aprepitant—Neuropathy peripheral—Carmustine—malignant glioma	0.00144	0.00505	CcSEcCtD
Aprepitant—Hyperglycaemia—Temozolomide—malignant glioma	0.00143	0.00504	CcSEcCtD
Aprepitant—Stomatitis—Carmustine—malignant glioma	0.00143	0.00502	CcSEcCtD
Aprepitant—Urinary tract infection—Carmustine—malignant glioma	0.00143	0.00501	CcSEcCtD
Aprepitant—Pneumonia—Temozolomide—malignant glioma	0.00143	0.00501	CcSEcCtD
Aprepitant—Infestation NOS—Temozolomide—malignant glioma	0.00142	0.00498	CcSEcCtD
Aprepitant—Infestation—Temozolomide—malignant glioma	0.00142	0.00498	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00141	0.00494	CcSEcCtD
Aprepitant—Neuropathy peripheral—Temozolomide—malignant glioma	0.00139	0.00488	CcSEcCtD
Aprepitant—Stomatitis—Temozolomide—malignant glioma	0.00138	0.00485	CcSEcCtD
Aprepitant—Urinary tract infection—Temozolomide—malignant glioma	0.00138	0.00484	CcSEcCtD
Aprepitant—Hypoaesthesia—Carmustine—malignant glioma	0.00131	0.0046	CcSEcCtD
Aprepitant—Hallucination—Carmustine—malignant glioma	0.00131	0.0046	CcSEcCtD
Aprepitant—Connective tissue disorder—Carmustine—malignant glioma	0.00129	0.00455	CcSEcCtD
Aprepitant—Hypoaesthesia—Temozolomide—malignant glioma	0.00127	0.00445	CcSEcCtD
Aprepitant—Hallucination—Temozolomide—malignant glioma	0.00127	0.00445	CcSEcCtD
Aprepitant—Pharyngitis—Temozolomide—malignant glioma	0.00126	0.00444	CcSEcCtD
Aprepitant—Urinary tract disorder—Temozolomide—malignant glioma	0.00126	0.00441	CcSEcCtD
Aprepitant—Connective tissue disorder—Temozolomide—malignant glioma	0.00125	0.00439	CcSEcCtD
Aprepitant—Urethral disorder—Temozolomide—malignant glioma	0.00125	0.00438	CcSEcCtD
Aprepitant—Eye disorder—Carmustine—malignant glioma	0.00123	0.00432	CcSEcCtD
Aprepitant—Flushing—Carmustine—malignant glioma	0.00122	0.00429	CcSEcCtD
Aprepitant—Erythema multiforme—Temozolomide—malignant glioma	0.0012	0.00423	CcSEcCtD
Aprepitant—Eye disorder—Temozolomide—malignant glioma	0.00119	0.00418	CcSEcCtD
Aprepitant—Tinnitus—Temozolomide—malignant glioma	0.00119	0.00417	CcSEcCtD
Aprepitant—Cardiac disorder—Temozolomide—malignant glioma	0.00118	0.00415	CcSEcCtD
Aprepitant—Flushing—Temozolomide—malignant glioma	0.00118	0.00415	CcSEcCtD
Aprepitant—Alopecia—Carmustine—malignant glioma	0.00116	0.00409	CcSEcCtD
Aprepitant—Angiopathy—Temozolomide—malignant glioma	0.00116	0.00406	CcSEcCtD
Aprepitant—Mental disorder—Carmustine—malignant glioma	0.00115	0.00405	CcSEcCtD
Aprepitant—Immune system disorder—Temozolomide—malignant glioma	0.00115	0.00404	CcSEcCtD
Aprepitant—Mediastinal disorder—Temozolomide—malignant glioma	0.00115	0.00403	CcSEcCtD
Aprepitant—Malnutrition—Carmustine—malignant glioma	0.00115	0.00403	CcSEcCtD
Aprepitant—Erythema—Carmustine—malignant glioma	0.00115	0.00403	CcSEcCtD
Aprepitant—Chills—Temozolomide—malignant glioma	0.00114	0.00401	CcSEcCtD
Aprepitant—Alopecia—Temozolomide—malignant glioma	0.00113	0.00395	CcSEcCtD
Aprepitant—Mental disorder—Temozolomide—malignant glioma	0.00112	0.00392	CcSEcCtD
Aprepitant—Back pain—Carmustine—malignant glioma	0.00111	0.00389	CcSEcCtD
Aprepitant—Erythema—Temozolomide—malignant glioma	0.00111	0.00389	CcSEcCtD
Aprepitant—Malnutrition—Temozolomide—malignant glioma	0.00111	0.00389	CcSEcCtD
Aprepitant—Dysgeusia—Temozolomide—malignant glioma	0.00109	0.00381	CcSEcCtD
Aprepitant—Tremor—Carmustine—malignant glioma	0.00107	0.00377	CcSEcCtD
Aprepitant—Back pain—Temozolomide—malignant glioma	0.00107	0.00376	CcSEcCtD
Aprepitant—Anaemia—Carmustine—malignant glioma	0.00106	0.00372	CcSEcCtD
Aprepitant—Tremor—Temozolomide—malignant glioma	0.00104	0.00365	CcSEcCtD
Aprepitant—Ill-defined disorder—Temozolomide—malignant glioma	0.00103	0.00361	CcSEcCtD
Aprepitant—Anaemia—Temozolomide—malignant glioma	0.00102	0.0036	CcSEcCtD
Aprepitant—Angioedema—Temozolomide—malignant glioma	0.00101	0.00356	CcSEcCtD
Aprepitant—Malaise—Temozolomide—malignant glioma	0.000999	0.00351	CcSEcCtD
Aprepitant—Convulsion—Carmustine—malignant glioma	0.000994	0.00349	CcSEcCtD
Aprepitant—Hypertension—Carmustine—malignant glioma	0.00099	0.00348	CcSEcCtD
Aprepitant—Palpitations—Temozolomide—malignant glioma	0.000979	0.00344	CcSEcCtD
Aprepitant—Chest pain—Carmustine—malignant glioma	0.000976	0.00343	CcSEcCtD
Aprepitant—Myalgia—Carmustine—malignant glioma	0.000976	0.00343	CcSEcCtD
Aprepitant—Anxiety—Carmustine—malignant glioma	0.000973	0.00342	CcSEcCtD
Aprepitant—Cough—Temozolomide—malignant glioma	0.000967	0.0034	CcSEcCtD
Aprepitant—Convulsion—Temozolomide—malignant glioma	0.00096	0.00337	CcSEcCtD
Aprepitant—Hypertension—Temozolomide—malignant glioma	0.000957	0.00336	CcSEcCtD
Aprepitant—Confusional state—Carmustine—malignant glioma	0.000944	0.00331	CcSEcCtD
Aprepitant—Myalgia—Temozolomide—malignant glioma	0.000944	0.00331	CcSEcCtD
Aprepitant—Arthralgia—Temozolomide—malignant glioma	0.000944	0.00331	CcSEcCtD
Aprepitant—Anxiety—Temozolomide—malignant glioma	0.00094	0.0033	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000937	0.00329	CcSEcCtD
Aprepitant—Oedema—Carmustine—malignant glioma	0.000936	0.00329	CcSEcCtD
Aprepitant—Discomfort—Temozolomide—malignant glioma	0.000932	0.00327	CcSEcCtD
Aprepitant—Infection—Carmustine—malignant glioma	0.00093	0.00326	CcSEcCtD
Aprepitant—Dry mouth—Temozolomide—malignant glioma	0.000923	0.00324	CcSEcCtD
Aprepitant—Thrombocytopenia—Carmustine—malignant glioma	0.000916	0.00322	CcSEcCtD
Aprepitant—Tachycardia—Carmustine—malignant glioma	0.000913	0.00321	CcSEcCtD
Aprepitant—Confusional state—Temozolomide—malignant glioma	0.000912	0.0032	CcSEcCtD
Aprepitant—Anaphylactic shock—Temozolomide—malignant glioma	0.000905	0.00318	CcSEcCtD
Aprepitant—Oedema—Temozolomide—malignant glioma	0.000905	0.00318	CcSEcCtD
Aprepitant—Infection—Temozolomide—malignant glioma	0.000899	0.00315	CcSEcCtD
Aprepitant—Anorexia—Carmustine—malignant glioma	0.000892	0.00313	CcSEcCtD
Aprepitant—Nervous system disorder—Temozolomide—malignant glioma	0.000887	0.00311	CcSEcCtD
Aprepitant—Thrombocytopenia—Temozolomide—malignant glioma	0.000886	0.00311	CcSEcCtD
Aprepitant—Skin disorder—Temozolomide—malignant glioma	0.000879	0.00308	CcSEcCtD
Aprepitant—Hypotension—Carmustine—malignant glioma	0.000875	0.00307	CcSEcCtD
Aprepitant—Hyperhidrosis—Temozolomide—malignant glioma	0.000874	0.00307	CcSEcCtD
Aprepitant—Anorexia—Temozolomide—malignant glioma	0.000862	0.00303	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000853	0.00299	CcSEcCtD
Aprepitant—Insomnia—Carmustine—malignant glioma	0.000847	0.00297	CcSEcCtD
Aprepitant—Paraesthesia—Carmustine—malignant glioma	0.00084	0.00295	CcSEcCtD
Aprepitant—Dyspnoea—Carmustine—malignant glioma	0.000834	0.00293	CcSEcCtD
Aprepitant—Somnolence—Carmustine—malignant glioma	0.000832	0.00292	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000824	0.00289	CcSEcCtD
Aprepitant—Insomnia—Temozolomide—malignant glioma	0.000818	0.00287	CcSEcCtD
Aprepitant—Decreased appetite—Carmustine—malignant glioma	0.000814	0.00286	CcSEcCtD
Aprepitant—Paraesthesia—Temozolomide—malignant glioma	0.000812	0.00285	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Carmustine—malignant glioma	0.000808	0.00284	CcSEcCtD
Aprepitant—Dyspnoea—Temozolomide—malignant glioma	0.000806	0.00283	CcSEcCtD
Aprepitant—Somnolence—Temozolomide—malignant glioma	0.000804	0.00282	CcSEcCtD
Aprepitant—Constipation—Carmustine—malignant glioma	0.0008	0.00281	CcSEcCtD
Aprepitant—Pain—Carmustine—malignant glioma	0.0008	0.00281	CcSEcCtD
Aprepitant—Dyspepsia—Temozolomide—malignant glioma	0.000796	0.0028	CcSEcCtD
Aprepitant—Decreased appetite—Temozolomide—malignant glioma	0.000786	0.00276	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000781	0.00274	CcSEcCtD
Aprepitant—Fatigue—Temozolomide—malignant glioma	0.00078	0.00274	CcSEcCtD
Aprepitant—Pain—Temozolomide—malignant glioma	0.000773	0.00272	CcSEcCtD
Aprepitant—Constipation—Temozolomide—malignant glioma	0.000773	0.00272	CcSEcCtD
Aprepitant—Feeling abnormal—Carmustine—malignant glioma	0.000771	0.00271	CcSEcCtD
Aprepitant—Gastrointestinal pain—Carmustine—malignant glioma	0.000765	0.00269	CcSEcCtD
Aprepitant—Feeling abnormal—Temozolomide—malignant glioma	0.000745	0.00262	CcSEcCtD
Aprepitant—Body temperature increased—Carmustine—malignant glioma	0.00074	0.0026	CcSEcCtD
Aprepitant—Abdominal pain—Carmustine—malignant glioma	0.00074	0.0026	CcSEcCtD
Aprepitant—Gastrointestinal pain—Temozolomide—malignant glioma	0.00074	0.0026	CcSEcCtD
Aprepitant—Urticaria—Temozolomide—malignant glioma	0.000719	0.00252	CcSEcCtD
Aprepitant—Abdominal pain—Temozolomide—malignant glioma	0.000715	0.00251	CcSEcCtD
Aprepitant—Body temperature increased—Temozolomide—malignant glioma	0.000715	0.00251	CcSEcCtD
Aprepitant—Hypersensitivity—Carmustine—malignant glioma	0.00069	0.00242	CcSEcCtD
Aprepitant—Asthenia—Carmustine—malignant glioma	0.000672	0.00236	CcSEcCtD
Aprepitant—Hypersensitivity—Temozolomide—malignant glioma	0.000666	0.00234	CcSEcCtD
Aprepitant—Asthenia—Temozolomide—malignant glioma	0.000649	0.00228	CcSEcCtD
Aprepitant—Diarrhoea—Carmustine—malignant glioma	0.00064	0.00225	CcSEcCtD
Aprepitant—Pruritus—Temozolomide—malignant glioma	0.00064	0.00225	CcSEcCtD
Aprepitant—Dizziness—Carmustine—malignant glioma	0.000619	0.00217	CcSEcCtD
Aprepitant—Diarrhoea—Temozolomide—malignant glioma	0.000619	0.00217	CcSEcCtD
Aprepitant—Dizziness—Temozolomide—malignant glioma	0.000598	0.0021	CcSEcCtD
Aprepitant—Vomiting—Carmustine—malignant glioma	0.000595	0.00209	CcSEcCtD
Aprepitant—Rash—Carmustine—malignant glioma	0.00059	0.00207	CcSEcCtD
Aprepitant—Dermatitis—Carmustine—malignant glioma	0.00059	0.00207	CcSEcCtD
Aprepitant—Headache—Carmustine—malignant glioma	0.000586	0.00206	CcSEcCtD
Aprepitant—Vomiting—Temozolomide—malignant glioma	0.000575	0.00202	CcSEcCtD
Aprepitant—Rash—Temozolomide—malignant glioma	0.00057	0.002	CcSEcCtD
Aprepitant—Dermatitis—Temozolomide—malignant glioma	0.00057	0.002	CcSEcCtD
Aprepitant—Headache—Temozolomide—malignant glioma	0.000567	0.00199	CcSEcCtD
Aprepitant—Nausea—Carmustine—malignant glioma	0.000556	0.00195	CcSEcCtD
Aprepitant—Nausea—Temozolomide—malignant glioma	0.000537	0.00189	CcSEcCtD
Aprepitant—CYP3A4—central nervous system—malignant glioma	0.000441	0.00948	CbGeAlD
Aprepitant—TACR3—Signaling Pathways—CASP3—malignant glioma	8.69e-05	0.0004	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—malignant glioma	8.68e-05	0.000399	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.66e-05	0.000398	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP3—malignant glioma	8.63e-05	0.000397	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CB—malignant glioma	8.6e-05	0.000396	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN2B—malignant glioma	8.55e-05	0.000393	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTK2—malignant glioma	8.31e-05	0.000382	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—IDH2—malignant glioma	8.29e-05	0.000381	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCL8—malignant glioma	8.27e-05	0.00038	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—malignant glioma	8.21e-05	0.000378	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PTEN—malignant glioma	8.17e-05	0.000376	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.16e-05	0.000375	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HES1—malignant glioma	8.16e-05	0.000375	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NCOR1—malignant glioma	8.11e-05	0.000373	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—RAF1—malignant glioma	8e-05	0.000368	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AKT1—malignant glioma	7.97e-05	0.000366	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ASMT—malignant glioma	7.91e-05	0.000364	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—malignant glioma	7.9e-05	0.000363	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.9e-05	0.000363	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CB—malignant glioma	7.81e-05	0.000359	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2B6—malignant glioma	7.8e-05	0.000359	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PDGFRA—malignant glioma	7.77e-05	0.000357	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPP1—malignant glioma	7.54e-05	0.000347	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—RTEL1—malignant glioma	7.53e-05	0.000346	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL8—malignant glioma	7.51e-05	0.000345	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.45e-05	0.000342	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BCAN—malignant glioma	7.44e-05	0.000342	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—malignant glioma	7.38e-05	0.000339	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.35e-05	0.000338	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—STAT3—malignant glioma	7.3e-05	0.000336	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—COX8A—malignant glioma	7.19e-05	0.000331	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—malignant glioma	7.18e-05	0.00033	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TERT—malignant glioma	7.15e-05	0.000329	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—IDH1—malignant glioma	7.13e-05	0.000328	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PDGFB—malignant glioma	6.98e-05	0.000321	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.97e-05	0.000321	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGFR1—malignant glioma	6.94e-05	0.000319	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SPHK1—malignant glioma	6.9e-05	0.000317	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HIF1A—malignant glioma	6.84e-05	0.000314	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MYC—malignant glioma	6.79e-05	0.000312	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2C18—malignant glioma	6.76e-05	0.000311	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.75e-05	0.00031	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EGFR—malignant glioma	6.64e-05	0.000305	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CAV1—malignant glioma	6.61e-05	0.000304	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—COX8A—malignant glioma	6.56e-05	0.000302	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KDR—malignant glioma	6.54e-05	0.000301	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.43e-05	0.000296	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—F2—malignant glioma	6.29e-05	0.000289	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FN1—malignant glioma	6.29e-05	0.000289	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—KRAS—malignant glioma	6.27e-05	0.000288	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BAD—malignant glioma	6.22e-05	0.000286	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH1—malignant glioma	6.16e-05	0.000283	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ASMT—malignant glioma	6.12e-05	0.000281	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CD80—malignant glioma	6.03e-05	0.000277	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APC—malignant glioma	6.02e-05	0.000277	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CG—malignant glioma	6.02e-05	0.000277	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—IDH2—malignant glioma	5.99e-05	0.000276	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.98e-05	0.000275	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGF—malignant glioma	5.95e-05	0.000274	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTPN11—malignant glioma	5.92e-05	0.000272	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.86e-05	0.00027	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CA—malignant glioma	5.76e-05	0.000265	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCAN—malignant glioma	5.75e-05	0.000264	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BRAF—malignant glioma	5.66e-05	0.00026	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.64e-05	0.000259	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—COX8A—malignant glioma	5.6e-05	0.000258	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ASMT—malignant glioma	5.58e-05	0.000256	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—malignant glioma	5.57e-05	0.000256	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT2—malignant glioma	5.51e-05	0.000253	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—malignant glioma	5.49e-05	0.000252	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTT1—malignant glioma	5.47e-05	0.000251	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.45e-05	0.000251	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CD—malignant glioma	5.3e-05	0.000243	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—malignant glioma	5.24e-05	0.000241	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCAN—malignant glioma	5.24e-05	0.000241	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—KRAS—malignant glioma	5.18e-05	0.000238	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—IDH1—malignant glioma	5.16e-05	0.000237	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS1—malignant glioma	5.12e-05	0.000236	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGF2—malignant glioma	5.07e-05	0.000233	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.01e-05	0.00023	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SPHK1—malignant glioma	4.99e-05	0.000229	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2C18—malignant glioma	4.89e-05	0.000225	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ASMT—malignant glioma	4.77e-05	0.000219	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BCHE—malignant glioma	4.76e-05	0.000219	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—malignant glioma	4.76e-05	0.000219	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MDM2—malignant glioma	4.74e-05	0.000218	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RAF1—malignant glioma	4.73e-05	0.000217	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—malignant glioma	4.71e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC5A5—malignant glioma	4.7e-05	0.000216	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB2—malignant glioma	4.68e-05	0.000215	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.66e-05	0.000214	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—IDH2—malignant glioma	4.63e-05	0.000213	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CB—malignant glioma	4.62e-05	0.000212	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCAN—malignant glioma	4.48e-05	0.000206	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—malignant glioma	4.44e-05	0.000204	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.37e-05	0.000201	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2B6—malignant glioma	4.36e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—COX8A—malignant glioma	4.33e-05	0.000199	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—malignant glioma	4.28e-05	0.000197	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—malignant glioma	4.25e-05	0.000195	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—malignant glioma	4.24e-05	0.000195	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—IDH2—malignant glioma	4.23e-05	0.000194	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—malignant glioma	4.01e-05	0.000184	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTEN—malignant glioma	3.99e-05	0.000183	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—IDH1—malignant glioma	3.99e-05	0.000183	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.98e-05	0.000183	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.97e-05	0.000183	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTT1—malignant glioma	3.95e-05	0.000182	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—malignant glioma	3.89e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SPHK1—malignant glioma	3.86e-05	0.000177	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTP1—malignant glioma	3.79e-05	0.000174	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.78e-05	0.000174	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS1—malignant glioma	3.7e-05	0.00017	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAT—malignant glioma	3.69e-05	0.00017	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ASMT—malignant glioma	3.68e-05	0.000169	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—IDH1—malignant glioma	3.63e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—IDH2—malignant glioma	3.61e-05	0.000166	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—malignant glioma	3.6e-05	0.000166	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—malignant glioma	3.57e-05	0.000164	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.56e-05	0.000164	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SPHK1—malignant glioma	3.52e-05	0.000162	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NCOR1—malignant glioma	3.48e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCAN—malignant glioma	3.46e-05	0.000159	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.44e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BCHE—malignant glioma	3.44e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.41e-05	0.000157	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.4e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.4e-05	0.000156	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—malignant glioma	3.31e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.25e-05	0.000149	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.25e-05	0.000149	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—malignant glioma	3.24e-05	0.000149	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.13e-05	0.000144	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—IDH1—malignant glioma	3.11e-05	0.000143	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KRAS—malignant glioma	3.06e-05	0.000141	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTT1—malignant glioma	3.06e-05	0.000141	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SPHK1—malignant glioma	3e-05	0.000138	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.96e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.94e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS1—malignant glioma	2.86e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.86e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.85e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—malignant glioma	2.84e-05	0.000131	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—malignant glioma	2.81e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH2—malignant glioma	2.79e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—malignant glioma	2.79e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.78e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—malignant glioma	2.74e-05	0.000126	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—malignant glioma	2.72e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAT—malignant glioma	2.67e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCHE—malignant glioma	2.66e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.63e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.62e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS1—malignant glioma	2.61e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.6e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.59e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.53e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NCOR1—malignant glioma	2.52e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—malignant glioma	2.5e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.49e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.46e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.44e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCHE—malignant glioma	2.43e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.4e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH1—malignant glioma	2.4e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—malignant glioma	2.38e-05	0.000109	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SPHK1—malignant glioma	2.32e-05	0.000107	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—malignant glioma	2.3e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.27e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.27e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.27e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.25e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS1—malignant glioma	2.23e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.22e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.15e-05	9.88e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—malignant glioma	2.12e-05	9.74e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCHE—malignant glioma	2.07e-05	9.54e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAT—malignant glioma	2.06e-05	9.48e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—malignant glioma	2.05e-05	9.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.05e-05	9.42e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.98e-05	9.11e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—malignant glioma	1.96e-05	9.03e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-05	9.01e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NCOR1—malignant glioma	1.95e-05	8.95e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.94e-05	8.91e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—malignant glioma	1.93e-05	8.88e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.92e-05	8.83e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAT—malignant glioma	1.88e-05	8.64e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.87e-05	8.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—malignant glioma	1.84e-05	8.45e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—malignant glioma	1.8e-05	8.3e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NCOR1—malignant glioma	1.77e-05	8.16e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS1—malignant glioma	1.72e-05	7.92e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—malignant glioma	1.71e-05	7.87e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.67e-05	7.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—malignant glioma	1.65e-05	7.59e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.64e-05	7.56e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAT—malignant glioma	1.61e-05	7.38e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCHE—malignant glioma	1.6e-05	7.36e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—malignant glioma	1.59e-05	7.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.58e-05	7.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOR1—malignant glioma	1.52e-05	6.97e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.52e-05	6.97e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—malignant glioma	1.45e-05	6.65e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.45e-05	6.65e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.43e-05	6.59e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—malignant glioma	1.42e-05	6.53e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—malignant glioma	1.39e-05	6.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	6.36e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.32e-05	6.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—malignant glioma	1.27e-05	5.86e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—malignant glioma	1.27e-05	5.85e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.27e-05	5.84e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAT—malignant glioma	1.24e-05	5.7e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—malignant glioma	1.24e-05	5.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—malignant glioma	1.24e-05	5.68e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.21e-05	5.55e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.18e-05	5.43e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOR1—malignant glioma	1.17e-05	5.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.16e-05	5.33e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.13e-05	5.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.11e-05	5.09e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—malignant glioma	1.1e-05	5.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—malignant glioma	1.09e-05	5e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.01e-05	4.64e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—malignant glioma	1e-05	4.6e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CD—malignant glioma	9.9e-06	4.55e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—malignant glioma	9.87e-06	4.54e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—malignant glioma	9.57e-06	4.4e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—malignant glioma	9.54e-06	4.39e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—malignant glioma	8.73e-06	4.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—malignant glioma	8.73e-06	4.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.69e-06	4e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.63e-06	3.97e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—malignant glioma	8.55e-06	3.93e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—malignant glioma	8.39e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.64e-06	3.51e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—malignant glioma	7.46e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—malignant glioma	7.13e-06	3.28e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—malignant glioma	6.75e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.66e-06	3.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—malignant glioma	6.6e-06	3.03e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.16e-06	2.83e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—malignant glioma	5.75e-06	2.65e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—malignant glioma	5.51e-06	2.54e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.26e-06	2.42e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—malignant glioma	5.03e-06	2.31e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—malignant glioma	4.3e-06	1.98e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.06e-06	1.87e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—malignant glioma	3.32e-06	1.52e-05	CbGpPWpGaD
